-
News | 2022.07.22
Improving bacterial strain classification for more effective surveillance
Genomic research on bacterial strains can provide the tools to develop a new classification system, leading to improved epidemiological surveillance, especially for antibiotic-resistant strains.
-
News | 2024.11.04
A novel method for producing DNA-based therapies
Scientists have combined enzyme and chemical techniques to develop an innovative method for producing synthetic DNA molecules. This novel approach opens up many new possibilities, especially for the production of large molecules that can be used for future therapies.
-
News | 2020.06.18
Phylogenetic analysis of SARS-CoV-2: strengths, limitations and over-interpretations
The Institut Pasteur's bioinformatics research teams have been closely involved in the response to COVID-19, working to analyze the sequencing data produced worldwide. On January 29, 2020, the Institut Pasteur, which is responsible for monitoring respiratory viruses in France, was the first in Europe to sequence the whole genome of the coronavirus known as SARS-CoV-2. Since then, it has sequenced...
-
Document de presse | 2020.10.16
Team of international scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses
Driven by Molecular Insights, Massive Analysis of Medical Records from ~740,000 SARS-CoV-2 Patients Reveal Treatment Regimens for Current, and Potential Future, Viral Pandemics. Published on October 15, 2020, in Science. In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the...
-
News | 2021.02.15
Discovery of messenger RNA in 1961
Since the beginning of the COVID-19 pandemic, words that just a year ago would have been the preserve of scientists have entered everyday language. One example is PCR, used for diagnostic tests. Another term that was once unfamiliar and is now on everyone's lips is messenger RNA, the miraculous molecule that has led to vaccines being administered to the general population less than a year after...
-
News | 2023.06.16
Strategic Plan: research advances in 2022
Five major themes were at the core of 2022 research advances: emerging infectious diseases, antimicrobial resistance, brain connectivity and neurodegenerative diseases, cancer, vaccinology and immunotherapy. They have honored Institut Pasteur's 2019-2023 strategic plan.
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
Document de presse | 2024.11.12
A*STAR IDL and Institut Pasteur unite their expertise to boost infectious diseases research across the asia-pacific region
Singapore’s Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) and France’s Institut Pasteur have signed a Memorandum of Understanding (MoU) to address the urgent health threats posed by the rise of tropical infectious diseases (ID) in the Asia-Pacific region. Together, this partnership would enable both parties to co-develop innovative technologies with...
-
Fiche maladie | 2015.10.06
Sepsis / Septicemia
Sepsis is the term used internationally to describe a widespread inflammatory response that occurs as a result of severe infection. Septicemia, the term coined in 1837 by French doctor Pierre Piorry from the Greek words "σήψις" (sêptikós), putrefaction, and "αίμα" (haîma), blood, refers to the presence of bacteria (or fungi or viruses) in the blood. Sepsis primarily affects people with weak...
-
Fiche maladie | 2015.10.06
Whooping cough (pertussis)
Whooping cough, long thought of as a childhood illness, can be severe at any age. This bacterial infection is particularly dangerous, and sometimes even fatal, for unvaccinated or partially vaccinated infants and at-risk individuals such as pregnant women and elderly people.
